Literature DB >> 90841

Prostacyclin deficiency in thrombotic thrombocytopenic purpura.

C N Hensby, P J Lewis, P Hilgard, G J Mufti, J Hows, J Webster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90841     DOI: 10.1016/s0140-6736(79)90680-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 2.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

Review 3.  Prostaglandins and the cardiovascular system.

Authors:  J R Vane
Journal:  Br Heart J       Date:  1983-05

4.  Prostacyclin infusion in haemolytic-uraemic syndrome of children.

Authors:  T J Beattie; A V Murphy; M L Willoughby; J J Belch
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-15

5.  Thrombotic thrombocytopenic purpura associated with the acquired immune deficiency syndrome.

Authors:  A Kumar; J Wang; D Sutton; E J Bow
Journal:  Can J Infect Dis       Date:  1992-01

6.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

7.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

8.  Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.

Authors:  E C Lian; P T Mui; F A Siddiqui; A Y Chiu; L L Chiu
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

9.  Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.

Authors:  S H Lee; J S Wainscoat; H Zeitlin; F G Bolton; H A Leaver; A Seawright; J M Preece
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

10.  Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells.

Authors:  T Yamauchi; F Umeda; M Masakado; M Isaji; S Mizushima; H Nawata
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.